Photorefractive keratectomy (PRK) was the original excimer laser procedure approved by the FDA—and is still a safe and effective treatment of refractive errors. PRK has the benefits of no-flap creation; therefore, there is no risk of flap complications.
At its fourth annual gathering at Vision Expo East, the Global Contact Lens Forum addressed developing technologies with research and development (R&D) scientists, evidence-based eye care, and contact lens practice settings.
As primary-care optometrists, we are the gatekeepers for baby boomers inquiring about cataract surgery. Today’s patients have treatment options available not only to address their lifestyle complaints but to provide them with better vision and possibly reduced dependence on glasses or contact lenses.
With much of the digital revolution occurring after 2008 and most contact lens technology developing well before it, there is an inherent design feature mismatch. The majority of the available contact lenses are not designed for how patients are using their eyes.
Ready for some big news? Johnson & Johnson announced they have entered into a definitive agreement to acquire Abbott Medical Optics (AMO) for $4.325 billion in cash. AMO’s business segments include cataract surgery, laser refractive surgery, and consumer eye health, and reported sales in 2015 were $1.1 billion.
1-800 Contacts is ramping up its fight against organized optometry at the state and federal levels over legislation that would change important aspects of contact lens prescriptions and dispensing, such as longer expiration dates, elimination of contact lens brand on the Rx, and enacting a contact lens patient bill of rights.
Johnson & Johnson Vision Care (JJVC) has discontinued its unilateral pricing policy (UPP) in an effort to focus the company’s resources on strengthening the doctor-patient relationship and advocating against contact lens deregulation. In UPP’s place, JJVC will be launching a new patient rewards program. This change is effective April 13, 2016.